pressat5 小时
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical ...
The Phase III trial AV001 aims to evaluate QUTENZA ® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical ...
Medscape15 小时
Costs of Common Neurologic Meds Continue to Rise
Investigators calculated annual OOP and total medication costs for five common neurological diseases. These included 186,144 ...
Knowridge4 天
Research finds the best drug for nerve pain
Neuropathic pain affects more than 20 million people in the U.S., and at least a quarter of these cases are puzzling for ...
Monthly Prescribing Reference5 天
Generic Medications Can Keep OOP Costs Down for Neurological Conditions
(HealthDay News) — Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, for which costs continue to increase, according to a ...
McKnight's Long-Term Care News6 天
Report: Parkinson’s, Alzheimer’s drug costs soared over nearly decade; MS meds rose most
People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...